Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Gross Margin of 4.64% for Q1 2026, down 97.0% on a YoY basis from 154.54% in Q1 2025, and down 97.46% sequentially from 182.84% in Q4 2025.
Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Gross Margin data on file, last reported at 4.64% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 97.0% year-over-year to 4.64%; the trailing twelve-month figure through Mar 2026 stood at 83.95% (up 9376.0% YoY), and the FY2025 full-year result was 80.47%, up 5548.0% from the prior year.
- Gross Margin slipped to 4.64% in Q1 2026, from 182.84% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 182.84% in Q4 2025 to a low of 197.19% in Q4 2022.
- A 5-year average of 19.84% and a median of 25.85% in 2023 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 26023 bps in 2022 and soared 27172 bps in 2025, its largest moves.
- Tracing RPID's Gross Margin over 5 years: stood at 197.19% in 2022, then jumped by 113 bps to 25.85% in 2023, then sank by 444 bps to 88.88% in 2024, then surged by 306 bps to 182.84% in 2025, then slumped by 97 bps to 4.64% in 2026.
- Business Quant data shows RPID's Gross Margin at 4.64% in Q1 2026, 182.84% in Q4 2025, and 29.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 4.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.64% |
| Dec 31, 2025 | 182.84% |
| Sep 30, 2025 | 29.03% |
| Jun 30, 2025 | 76.98% |
| Mar 31, 2025 | 5.61% |
| Dec 31, 2024 | -88.88% |
| Sep 30, 2024 | 30.12% |
| Jun 30, 2024 | 25.70% |
| Mar 31, 2024 | 7.81% |
| Dec 31, 2023 | 25.85% |
| Sep 30, 2023 | 7.39% |
| Jun 30, 2023 | 55.92% |
| Mar 31, 2023 | 1.07% |
| Dec 31, 2022 | -197.19% |
| Sep 30, 2022 | 59.78% |
| Jun 30, 2022 | 52.18% |
| Mar 31, 2022 | 58.51% |
| Dec 31, 2021 | 63.04% |
| Sep 30, 2021 | 78.03% |
| Jun 30, 2021 | 92.30% |